---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-096796"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T01:49:37.349555+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Adial stockholders approve 4x increase in equity plan shares to 2M; directors re-elected

## Summary
- Amendment No. 6 to 2017 Equity Incentive Plan approved, raising authorized shares from 500,000 to 2,000,000.
- J. Kermit Anderson and James W. Newman Jr. re-elected as Class III directors through 2027.
- Marcum LLP ratified as independent auditor for fiscal year ending December 31, 2024.
- Advisory vote on executive compensation approved; board sets future advisory vote every three years.
- Broker non-votes of ~2.3M shares on director election and plan amendment, reflecting significant institutional abstentions.

## SEC filing metadata
- accession: 0001213900-24-096796
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390024096796/0001213900-24-096796-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390024096796/ea0220869-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-096796
- JSON: https://secwatch.observer/filing/0001213900-24-096796.json
- Plain text: https://secwatch.observer/filing/0001213900-24-096796.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.